Dopaminergic Modulation of Declarative Memory

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Parkinson's Disease
Interventions
DRUG

Dopamine Agent

"Patients were assessed in two experimental conditions that were performed on different days, with an intersession interval of about one month. In the off condition PD subjects performed the experimental tasks in the morning after 12/18 hours of Dopamine Agent withdrawal. In the on condition they were examined 90-120 minutes after they had taken their first morning dose of levodopa and/or dopamine agonists."

Trial Locations (1)

00179

Fondazione S. Lucia, Rome

All Listed Sponsors
lead

I.R.C.C.S. Fondazione Santa Lucia

OTHER

NCT03151460 - Dopaminergic Modulation of Declarative Memory | Biotech Hunter | Biotech Hunter